Open0.580 | Close0.533 |
Vol / Avg.56.030K / 76.249K | Mkt Cap20.014M |
Day Range0.520 - 0.580 | 52 Wk Range0.450 - 1.730 |
Equillium Stock (NASDAQ: EQ) stock price, news, charts, stock research, profile.
Open0.580 | Close0.533 |
Vol / Avg.56.030K / 76.249K | Mkt Cap20.014M |
Day Range0.520 - 0.580 | 52 Wk Range0.450 - 1.730 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.210 | -0.110 | 0.1000 | ||||
REV | 8.000M | 8.870M | 870.000K |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.210 | -0.100 | 0.1100 | ||||
REV | 8.000M | 9.124M | 1.124M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-11-13 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | BuyBuy | Lowers | 5.50 | 4.50 |
2023-08-14 | Cantor Fitzgerald | Emma Nealon | Reiterates | OverweightOverweight | Maintains | - | 2.80 |
2023-08-14 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 5.50 |
2023-05-15 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 5.50 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
EQ | Equillium | -1.72% | 20M |
GLTO | Galecto | -5.52% | 16.1M |
CLRB | Cellectar Biosciences | 0.4% | 24.7M |
PHXM | PHAXIAM Therapeutics | 22.5% | 29.8M |
EVAX | Evaxion Biotech | 2.6% | 22.9M |
You can purchase shares of Equillium (NASDAQ: EQ) through any online brokerage.
Other companies in Equillium’s space includes: Galecto (NASDAQ:GLTO), Cellectar Biosciences (NASDAQ:CLRB), PHAXIAM Therapeutics (NASDAQ:PHXM), Evaxion Biotech (NASDAQ:EVAX) and Lumos Pharma (NASDAQ:LUMO).
The latest price target for Equillium (NASDAQ: EQ) was reported by HC Wainwright & Co. on Monday, November 13, 2023. The analyst firm set a price target for 4.50 expecting EQ to rise to within 12 months (a possible 689.61% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Equillium (NASDAQ: EQ) is $0.5699 last updated November 30, 2023 at 10:58 PM UTC.
There is no dividend information for Equillium.
Equillium’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Equillium.
Equillium is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.